M. Gerlach

发表

Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum

P. Riederer, K. Double, M. Gerlach, 2003, Journal of Neural Transmission.

Caenorhabditis elegans MPP+ Model of Parkinson’s Disease for High-Throughput Drug Screenings

P. Riederer, M. Gerlach, E. Braungart, 2004, Neurodegenerative Diseases.

Influence of a genetic variant of the neuronal growth associated protein Stathmin 1 on cognitive and affective control processes: An event‐related potential study

K. Lesch, M. Herrmann, A. Ehlis, 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Neurobiologie des Aufmerksamkeitsdefizit-/Hyperaktivitätssyndroms

K. Lesch, M. Herrmann, A. Fallgatter, 2008, Der Nervenarzt.

Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD

A. Ehlis, A. Fallgatter, J. Thome, 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Annual report 2015

M. Gerlach, 2016, ADHD Attention Deficit and Hyperactivity Disorders.

A systematic review on olfaction in child and adolescent psychiatric disorders

C. Freitag, M. Schecklmann, M. Gerlach, 2012, Journal of Neural Transmission.

High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study

A. Wuerz, P. Riederer, S. Petri, 2005, Journal of Neural Transmission.

Genes associated with Parkinson syndrome

Saskia Biskup, Thomas Gasser, Andreas Kupsch, 2008, Journal of Neurology.

Dopaminergic dysbalance in distinct basal ganglia neurocircuits: Implications for the pathophysiology of parkinson’s disease, schizophrenia and attention deficit hyperactivity disorder

P. Riederer, P. Riederer, M. Gerlach, 2006, Neurotoxicity Research.

Brain dopamine and kinematics of graphomotor functions.

Susanne Walitza, Oliver Tucha, Markus Naumann, 2006, Human movement science.

Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson’s Disease

L. Grinberg, R. Leite, P. Riederer, 2020, Cells.

Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients

Peter Riederer, H. Przuntek, P. Riederer, 1995, Neuroscience Letters.

Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes

M Gallorini, P Riederer, P. Riederer, 2001, Journal of neurochemistry.

Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26S proteasome

P. Riederer, M. Gerlach, M. Naoi, 2006, Journal of Neural Transmission.

Iron-binding characteristics of neuromelanin of the human substantia nigra.

P. Riederer, K. Double, D. Ben-shachar, 2003, Biochemical pharmacology.

Evidence for specific phases in the development of human neuromelanin

P. Riederer, G. M. Halliday, P. Riederer, 2006, Journal of Neural Transmission.

Evidence for specific phases in the development of human neuromelanin

P. Riederer, G. M. Halliday, P. Riederer, 2006, Neurobiology of Aging.

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

K Domschke, P Riederer, Matthias J. Müller, 2017, Pharmacopsychiatry.

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

K. Domschke, P. Riederer, M. Müller, 2018, Pharmacopsychiatry.

Mechanisms underlying and medical management of l-Dopa-associated motor complications

P. Riederer, M. Gerlach, D. Scheller, 2011, Journal of Neural Transmission.

A critical review of evidence for preclinical differences between rasagiline and selegiline

H. Reichmann, P. Riederer, M. Gerlach, 2012 .

Selegiline completely restores choline acetyltransferase activity deficits in simian immunodeficiency infection.

P. Riederer, M. Gerlach, V. Meulen, 2001, European journal of pharmacology.

Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline

A. Kupsch, W. Oertel, P. Riederer, 2001, Journal of Neural Transmission.

Apoptosis inhibition in T cells triggers the expression of proinflammatory cytokines--implications for the CNS.

P. Riederer, M. Gerlach, E. Koutsilieri, 2006, Journal of neural transmission. Supplementum.

Neurorestoration in Parkinson’s disease by cell replacement and endogenous regeneration

Johannes Schwarz, Alexander Storch, M. Gerlach, 2004, Expert opinion on biological therapy.

Structural Characteristics of Human Substantia Nigra Neuromelanin and Synthetic Dopamine Melanins

P. Riederer, K. Double, S. Ito, 2000, Journal of neurochemistry.

Relationship Between Amphetamine Concentrations in Saliva and Serum in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

M. Gerlach, M. Romanos, P. Högger, 2020, Therapeutic drug monitoring.

Perception in attention deficit hyperactivity disorder

M. Gerlach, O. Tucha, A. Fuermaier, 2018, ADHD Attention Deficit and Hyperactivity Disorders.

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level

A. Kupsch, W. Oertel, P. Riederer, 1996, Brain Research.

Treatment with antioxidants does not prevent loss of dopamine in the striatum of MPTP-treated common marmosets: Preliminary observations

H. Przuntek, P. Riederer, M. Gerlach, 1991, Journal of neural transmission. Parkinson's disease and dementia section.

Transcranial sonography in psychiatry as a potential tool in diagnosis and research

D. Berg, M. Gerlach, M. Romanos, 2018, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Therapeutic drug monitoring of children and adolescents treated with aripiprazole: observational results from routine patient care

M. Gerlach, C. Wewetzer, K. Egberts, 2020, Journal of Neural Transmission.

The effect of silyl substituted methotrexate in the treatment of experimental allergic encephalomyelitis in rats mediated by T-line cells

H. Przuntek, M. Gerlach, P. Jutzi, 1987, Neuropharmacology.

Proteomic research in psychiatry

J. Thome, M. Gerlach, A. Warnke, 2011, Journal of psychopharmacology.

Anxiolytics and Sedative-Hypnotics

M. Gerlach, A. Warnke, 2014 .

The Relation Between Dosage, Serum Concentrations, and Clinical Outcome in Children and Adolescents Treated With Sertraline: A Naturalistic Study

M. Gerlach, C. Wewetzer, K. Egberts, 2013, Therapeutic drug monitoring.

Norepinephrine is a negative regulator of the adult periventricular neural stem cell niche

C. Redecker, M. Gerlach, Julia Müller, 2020, Stem cells.

Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical Practice

M. Kaess, P. Heuschmann, C. Correll, 2022, Pharmacopsychiatry.

Mössbauer Spectroscopic Studies of Purified Human Neuromelanin Isolated from the Substantia Nigra

P. Riederer, M. Gerlach, L. Zecca, 1995, Journal of neurochemistry.

No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample

K. Lesch, S. Walitza, M. Gerlach, 2011, Attention deficit and hyperactivity disorders.

Lack of Hypoxia-Inducible Factor-1α Impairs Midbrain Neural Precursor Cells Involving Vascular Endothelial Growth Factor Signaling

R. Wenger, M. Gerlach, A. Storch, 2007, The Journal of Neuroscience.

LC with Column-Switching and Spectrophotometric Detection for Determination of Risperidone and 9-Hydroxyrisperidone in Human Serum

P. Riederer, M. Gerlach, C. Hiemke, 2008 .

Relationship Between Daily Dose, Serum Concentration, and Clinical Response to Quetiapine in Children and Adolescents with Psychotic and Mood Disorders

M. Gerlach, C. Wewetzer, K. Egberts, 2017, Pharmacopsychiatry.

beta-Amyloid deposition and prion infection in adult primary brain cell long-term culture model.

P. Riederer, M. Gerlach, Seong-Wook Yun, 2007, Biochemical and biophysical research communications.

Contribution of disturbed iron metabolism to the pathogenesis of Parkinson's disease

D. Berg, P. Riederer, M. Gerlach, 2008 .

Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells

Y. Akao, P. Riederer, M. Gerlach, 2004, Journal of Neural Transmission.

A novel technique for the isolation of Lewy bodies in brain

K. Jellinger, P. Riederer, M. Gerlach, 1998, Acta Neuropathologica.

Proteomic characterization of neuromelanin granules isolated from human substantia nigra by laser-microdissection

J. Attems, P. Riederer, M. Gerlach, 2016, Scientific Reports.

Coenzyme Q10 serum levels in Huntington's disease.

M. Gerlach, J. Andrich, C. Saft, 2004, Journal of neural transmission. Supplementum.

Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice.

A. Kupsch, W. Oertel, H. Przuntek, 1995, Neuroreport.

Pharmacokinetic studies with sustained-release formulations of levodopa in healthy volunteers.

H. Przuntek, M. Gerlach, W. Kuhn, 1988, Journal of neural transmission. Supplementum.

Altered redox state of platelet coenzyme Q10 in Parkinson's disease

P. Riederer, M. Gerlach, W. Kuhn, 2000, Journal of Neural Transmission.

Should the maximum daily doses of levodopa be limited to 400 mg/die?

M. Gerlach, W. Jost, D. Woitalla, 2014 .

(−)-Deprenyl treatment of patients with Parkinson's disease does not affect erythrocyte catechol-O-methyl transferase activity

H. Przuntek, M. Gerlach, W. Kuhn, 1991, Journal of neural transmission. Parkinson's disease and dementia section.

Chronic alcohol consumption and cerebral indices of oxidative stress: is there a link?

H. Reichmann, P. Riederer, M. Gerlach, 2001, Alcoholism, clinical and experimental research.

Levodopa in the treatment of Parkinson's disease: Current controversies

H. Reichmann, P. Riederer, M. Gerlach, 2005, Movement disorders : official journal of the Movement Disorder Society.

Glia Protects Neurons against Extracellular Human Neuromelanin

W. Oertel, P. Riederer, M. Gerlach, 2007, Neurodegenerative Diseases.

MAO-B inhibitors: multiple roles in the therapy of neurodegenerative disorders?

P. Riederer, M. Gerlach, M. Youdim, 2000, Parkinsonism & related disorders.

Effect of adding selegeline to levodopa in early, mild Parkinson's disease. "On treatment" rather than intention to treat analysis should have been used.

P. Riederer, M. Gerlach, H. Vogt, 1996, BMJ.

Acute MPTP treatment produces no changes in mitochondrial complex activities and indices of oxidative damage in the common marmoset ex vivo one week after exposure to the toxin

A. Kupsch, H. Reichmann, P. Riederer, 1996, Neurochemistry International.

The effect of piribedil on l-DOPA-induced dyskinesias in a rat model of Parkinson’s disease: differential role of α2 adrenergic mechanisms

P. Riederer, M. Gerlach, P. Halley, 2012, Journal of Neural Transmission.

Flibanserin attenuates l-DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson’s disease

P. Riederer, M. Gerlach, J. Beck, 2011, Journal of Neural Transmission.

Role of dopamine D3 and serotonin 5-HT1A receptors in l-DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson’s disease

P. Riederer, M. Gerlach, M. van den Buuse, 2011, Journal of Neural Transmission.

Pharmacokinetic investigations of various levodopa formulations

H. Przuntek, M. Gerlach, W. Kuhn, 1989 .

Transcriptional alterations under continuous or pulsatile dopaminergic treatment in dyskinetic rats

P. Riederer, M. Gerlach, E. Grünblatt, 2011, Journal of Neural Transmission.

Anti-melanin antibodies are increased in sera in Parkinson's disease

V. Fung, P. Riederer, K. Double, 2009, Experimental Neurology.

Neuromelanin is an immune stimulator for dendritic cells in vitro

P. Riederer, M. Gerlach, T. Arzberger, 2011, BMC Neuroscience.

The molecular pharmacology of L-deprenyl.

P. Riederer, M. Gerlach, M. Youdim, 1992, European journal of pharmacology.

Biological Role of Neuromelanin in the Human Brain and Its Importance in Parkinson's Disease

P. Riederer, K. Double, M. Gerlach, 2011 .

Neuromelanin selectively induces apoptosis in dopaminergic SH‐SY5Y cells by deglutathionylation in mitochondria: involvement of the protein and melanin component

Y. Akao, P. Riederer, M. Gerlach, 2008, Journal of neurochemistry.

GC/MS analysis of thermally degraded neuromelanin from the human substantia nigra

P. Riederer, M. Gerlach, T. Arzberger, 2004, Journal of the American Society for Mass Spectrometry.

Glutathione redox status in mitochondria and cytoplasm differentially and sequentially activates apoptosis cascade in dopamine-melanin-treated SH-SY5Y cells

Y. Akao, P. Riederer, M. Gerlach, 2009, Neuroscience Letters.

Formation of Radicals

M. Gerlach, M. Götz, 2004 .

The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants

P. Riederer, M. Gerlach, G. Laux, 2005, Dialogues in clinical neuroscience.

Effects of nimodipine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced depletions in the biogenic amine levels in mice.

H. Przuntek, P. Riederer, M. Gerlach, 1993, Arzneimittel-Forschung.

Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?

K. Lange, M. Gerlach, E. Grünblatt, 2013, ADHD Attention Deficit and Hyperactivity Disorders.

Improved Reproducibility of Protein Detection in Neuromelanin-containing Human Substantia Nigra Tissue enriched by Laser Microdissection

M. Savitski, P. Riederer, M. Gerlach, 2020 .

The Role of Iron in the Pathogenesis of Parkinson's Disease

P. Riederer, K. Double, M. Gerlach, 2006 .

Effects of secretin on extracellular amino acid concentrations in rat hippocampus

M. Gerlach, K. Hennighausen, D. van Calker, 2004, Journal of Neural Transmission.

MAO-B-Hemmer

P. Riederer, M. Gerlach, P. Fischer, 1992 .

Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cells

P. Riederer, K. Double, G. Halliday, 2005, Journal of neurochemistry.

Investigation of the lipid component of neuromelanin

P. Riederer, K. Double, G. Halliday, 2006, Journal of neural transmission.

Dolichol is the major lipid component of human substantia nigra neuromelanin

P. Riederer, K. Double, G. Halliday, 2005, Journal of neurochemistry.

Intraoperative microdialysis and tissue-pO2 measurement in human glioma.

J. Meixensberger, M. Gerlach, J. Lan, 1998, Acta neurochirurgica. Supplement.

Itches and scratches – is there a link between eczema, ADHD, sleep disruption and food hypersensitivity?

J. Schmitt, M. Gerlach, S. Weidinger, 2011, Allergy.

No genetic association between attention-deficit/hyperactivity disorder (ADHD) and Parkinson’s disease in nine ADHD candidate SNPs

D. Berg, M. Gerlach, C. Schulte, 2017, ADHD Attention Deficit and Hyperactivity Disorders.

Special edition on the occasion of Jan K. Buitelaar’s 65th anniversary

B. Franke, L. Rohde, T. Banaschewski, 2019, ADHD Attention Deficit and Hyperactivity Disorders.

Dose-Corrected Serum Concentrations and Metabolite to Parent Compound Ratios of Venlafaxine and Risperidone from Childhood to Old Age

M. Gerlach, S. Kittel-Schneider, K. Egberts, 2020, Pharmacopsychiatry.

Psychotropic drug concentrations and clinical outcomes in children and adolescents: a systematic review

M. Gerlach, M. Hillegers, K. Egberts, 2020, Expert opinion on drug safety.

Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes

P. Riederer, M. Gerlach, M. Eisenacher, 2022, Journal of Neural Transmission.

Structural investigations of neuromelanin by pyrolysis-gas chromatography/mass spectrometry

P. Riederer, M. Gerlach, E. Chodurek, 2006, Journal of Neural Transmission.

Trust, but verify. The errors and misinterpretations in the Cochrane analysis by O. J. Storebo and colleagues on the efficacy and safety of methylphenidate for the treatment of children and adolescents with ADHD.

T. Banaschewski, M. Gerlach, M. Holtmann, 2016, Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie.

Uniform pattern of immunohistochemical localization of serotonin 5-HT2 receptors in human aortic, mitral, pulmonary and tricuspid heart valves: Implication for the pathomechanism of valvular heart disease following treatment with dopamine agonists

P. Riederer, M. Gerlach, C. Monoranu, 2012 .

Tolcapone and neurotoxicity in Parkinson's disease

M. Gerlach, D. Woitalla, W. Kuhn, 1998, The Lancet.

Drug- or Substance-Related Disorders

M. Gerlach, G. Wiesbeck, R. Stohler, 2014 .

Effects of Selegiline in a retroviral rat model for neurodegenerative disease.

P. Riederer, M. Gerlach, V. ter meulen, 1999, Journal of neurovirology.

Pro-and Antioxidative Properties of Cortical Tissue Preparations from Human Brain Exhibiting NMDA-Receptor Characteristics

M. Elstner, P. Riederer, M. Gerlach, 1999, Zeitschrift fur Naturforschung. C, Journal of biosciences.

Evidence for increased oxidative stress in alcohol-dependent patients provided by quantification of in vivo salicylate hydroxylation products.

J. Thome, P. Riederer, M. Gerlach, 1997, Alcoholism, clinical and experimental research.

Long-term cardiovascular safety of psychostimulants in children with attention deficit hyperactivity disorder

T. Keil, M. Gerlach, A. Conzelmann, 2019, International journal of psychiatry in clinical practice.

Chronic TVP-1012 (rasagiline) dose--activity response of monoamine oxidases A and B in the brain of the common marmoset.

A. Kupsch, W. Oertel, P. Riederer, 1998, Journal of neural transmission. Supplementum.

Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride

M. Gerlach, C. Wewetzer, K. Egberts, 2020, European Journal of Clinical Pharmacology.

The Proteome of Neuromelanin Granules in Dementia with Lewy Bodies

P. Riederer, M. Gerlach, M. Eisenacher, 2022, Cells.

Abstracts Second Congress of the European Society for Clinical Neuropharmacology

K. Jellinger, L. Iversen, K. Lesch, 1995, Journal of Neural Transmission / General Section JNT.

Does the treatment of maternal attention deficit and hyperactivity disorder (ADHD) enhance the efficacy of a behavioural parent training for the treatment of their children’s ADHD? Study protocol of a randomized controlled multicentre trail

M. Gerlach, A. Warnke, A. Philipsen, 2009, Attention deficit and hyperactivity disorders.

Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy

A. Serretti, M. Gerlach, G. Gründer, 2022, Frontiers in Psychiatry.

The tyrosine kinase inhibitor imatinib mesylate delays prion neuroinvasion by inhibiting prion propagation in the periphery

P. Riederer, M. Gerlach, Seong-Wook Yun, 2011, Journal of NeuroVirology.

Unaltered susceptibility to scrapie in serotonin transporter deficient mice

K. Lesch, P. Riederer, M. Gerlach, 2006, Neurochemistry International.

Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice.

P. Riederer, M. Gerlach, J. Deckert, 2007, Journal of neural transmission. Supplementum.

Serious Adverse Drug Reactions to Antipsychotics in Minors with Multiple Disabilities: Preventability and Potential Cost Savings by Therapeutic Drug Monitoring

M. Gerlach, K. Egberts, M. Romanos, 2022, Pharmacopsychiatry.

Determination of Guanfacine in Oral Fluid and Serum of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Short Communication

M. Gerlach, M. Romanos, P. Högger, 2021, Therapeutic drug monitoring.

M. Gerlach, C. Hiemke, S. Fekete, 2020, Therapeutic drug monitoring.

TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians*

Matthias J. Müller, K. Domschke, P. Riederer, 2018, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Relationship between clozapine dose, serum concentration, and clinical outcome in children and adolescents in clinical practice

M. Gerlach, C. Wewetzer, K. Egberts, 2016, Journal of Neural Transmission.

[Pharmacovigilance in child and adolescent psychiatry].

M. Gerlach, M. Kölch, K. Egberts, 2015, Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie.

Therapeutic Drug Monitoring of Children and Adolescents Treated with Fluoxetine

M. Gerlach, J. Stingl, K. Egberts, 2011, Pharmacopsychiatry.

Therapeutic Drug Monitoring in Child and Adolescent Psychiatry

M. Gerlach, K. Egberts, C. Mehler-Wex, 2011, Pharmacopsychiatry.

Serum Concentrations, Therapeutic Response and Side Effects in Children and Adolescents with Impulsive-Aggressive Symptoms during Risperidone Therapy

M. Gerlach, C. Wewetzer, B. Pfuhlmann, 2009, Pharmacopsychiatry.

Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders.

M. Gerlach, C. Wewetzer, C. Mehler-Wex, 2007, Pharmacopsychiatry.

Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour

D. Sulzer, P. Riederer, M. Gerlach, 2001, Molecular pathology : MP.

AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.

Matthias J. Müller, P. Riederer, M. Gerlach, 2014, Pharmacopsychiatry.

“Subcellular Proteomics” of Neuromelanin Granules Isolated from the Human Brain*

P. Riederer, M. Gerlach, T. Arzberger, 2005, Molecular & Cellular Proteomics.

Neuromelanin in human dopamine neurons: Comparison with peripheral melanins and relevance to Parkinson's disease

P. Riederer, K. Double, G. Halliday, 2005, Progress in Neurobiology.

Psychiatric, nonmotor aspects of Parkinson's disease.

P. Riederer, M. Gerlach, M. Youdim, 2012, Handbook of clinical neurology.

Pharmacotherapy in depressed children and adolescents

J. Thome, M. Gerlach, A. Warnke, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Biochemical and pharmacological characterization of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline: a biologically relevant neurotoxin?

P. Riederer, M. Gerlach, D. Feineis, 2002, European journal of pharmacology.

N-methyl-(R)-salsolinol and its relevance to Parkinson's disease

P. Riederer, M. Gerlach, E. Koutsilieri, 1998, The Lancet.

The Mode of Action of MAO-B Inhibitors

P. Riederer, M. Gerlach, M. Youdim, 1993 .

The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

B Müller-Oerlinghausen, P Riederer, P. Riederer, 2004, Pharmacopsychiatry.

Neuroprotective Strategies in Parkinson’s Disease

Moussa B. H. Youdim, Peter Riederer, Yona Levites, 2003, CNS drugs.

Monoamin-Oxidase-Hemmer

U. Müller, P. Riederer, M. Gerlach, 2002 .

In Vitro Studies of Ferritin Iron Release and Neurotoxicity

P. Riederer, K. Double, M. Gerlach, 1998, Journal of neurochemistry.

Identification of L-ferritin in Neuromelanin Granules of the Human Substantia Nigra

Katrin Marcus, Thomas Arzberger, Peter Riederer, 2009, Molecular & Cellular Proteomics.

Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease

P. Riederer, K. Double, M. Gerlach, 2009, Neurotoxicity Research.

Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis.

P. Riederer, M. Gerlach, T. Arzberger, 2007, Journal of neural transmission. Supplementum.

Influence of neuromelanin on oxidative pathways within the human substantia nigra.

P. Riederer, K. Double, M. Gerlach, 2002, Neurotoxicology and teratology.

The neuromelanin of human substantia nigra: structure, synthesis and molecular behaviour.

D. Sulzer, P. Riederer, S. Ito, 2003, Journal of neural transmission. Supplementum.

Impaired iron homeostasis in Parkinson's disease.

P. Riederer, K. Double, M. Gerlach, 2000, Journal of neural transmission. Supplementum.

Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics

H. Hampel, D. Berg, J. Streffer, 2011, Journal of Neural Transmission.

Catecholaminergic Innervation of Periventricular Neurogenic Regions of the Developing Mouse Brain

M. Gerlach, A. Storch, M. Fauser, 2020, Frontiers in Neuroanatomy.

Brain iron pathways and their relevance to Parkinson's disease.

D. Berg, P. Riederer, K. Double, 2001, Journal of neurochemistry.

Absence of Thermal Hyperalgesia in Serotonin Transporter-Deficient Mice

Claudia Sommer, Dennis L. Murphy, Klaus-Peter Lesch, 2003, The Journal of Neuroscience.

Potential sources of increased iron in the substantia nigra of parkinsonian patients.

P. Riederer, K. Double, M. Gerlach, 2006, Journal of neural transmission. Supplementum.

Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity

P. Riederer, M. Gerlach, G. Bringmann, 2006, Journal of Neural Transmission.

Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man

P. Riederer, M. Gerlach, 2005, Journal of Neural Transmission.

Iron Deficiency and Excess in the Brain: Implications for Cognitive Impairment and Neurodegeneration

M. Gerlach, M. Youdim, P. Riederer, 2009 .

The Relevance of Iron in the Pathogenesis of Parkinson's Disease

K. Double, M. Gerlach, M. Youdim, 2004, Annals of the New York Academy of Sciences.

Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

P Riederer, H. Przuntek, P. Riederer, 1995, Neuroscience letters.

A pilot proteomic study of protein markers in autism spectrum disorder

Costel C. Darie, J. Thome, M. Gerlach, 2014, Electrophoresis.

The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder

B. Franke, S. Bölte, J. Swanson, 2021, Neuroscience & Biobehavioral Reviews.

Effects of methylphenidate: the cellular point of view

P. Riederer, S. Walitza, M. Gerlach, 2010, Attention deficit and hyperactivity disorders.

Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease

P. Riederer, M. Gerlach, T. Hennig, 2001, Molecular Psychiatry.

AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.

Matthias J. Müller, P. Riederer, M. Gerlach, 2014, Pharmacopsychiatry.

Serotonin transporter deficiency protects mice from mechanical allodynia and heat hyperalgesia in vincristine neuropathy

K. Lesch, M. Gerlach, C. Sommer, 2011, Neuroscience Letters.

Continuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movements

P. Riederer, M. Gerlach, E. Gruenblatt, 2008, Journal of Neural Transmission.

Basic science in Parkinson’s disease: its impact on clinical practice

J. Schulz, P. Riederer, M. Gerlach, 2011, Journal of Neurology.

Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson’s disease

J. Volkmann, D. Berg, P. Riederer, 2022, Journal of Neural Transmission.

Mesodermal cell types induce neurogenesis from adult human hippocampal progenitor cells

Johannes Schwarz, Holger Lerche, Stefan Liebau, 2006, Journal of neurochemistry.

Multipotent Neural Stem Cells from the Adult Tegmentum with Dopaminergic Potential Develop Essential Properties of Functional Neurons

M. Gerlach, Kwang-Soo Kim, Dong-Wook Kim, 2006, Stem cells.

Decreased anxiety in mice lacking the organic cation transporter 3

K. Lesch, M. Gerlach, A. Reif, 2009, Journal of Neural Transmission.

MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease.

H. Przuntek, P. Riederer, M. Gerlach, 1991, European journal of pharmacology.

5-hydroxyindolacetic acid (5-HIAA), a main metabolite of serotonin, is responsible for complete Freund's adjuvant-induced thermal hyperalgesia in mice

K. Lesch, M. Gerlach, C. Sommer, 2011, Molecular pain.

Altered mRNA expression of monoaminergic candidate genes in the blood of children with attention deficit hyperactivity disorder and autism spectrum disorder

J. Thome, M. Schecklmann, S. Walitza, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition.

C. Wessig, S. Hallermann, M. Gerlach, 2010, Brain : a journal of neurology.

Child and Adolescent Psychiatry and Mental Health Drug Monitoring in Child and Adolescent Psychiatry for Improved Efficacy and Safety of Psychopharmacotherapy

M. Gerlach, M. Kölch, J. Fegert, 2022 .

Potential biomarkers in psychiatry: focus on the cholesterol system

Costel C. Darie, J. Thome, M. Gerlach, 2012, Journal of cellular and molecular medicine.

A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome

K. Jellinger, J. Kornhuber, P. Riederer, 1996, Brain Research.

Microglia activation is related to substantia nigra echogenicity

D. Berg, P. Riederer, M. Gerlach, 2010, Journal of Neural Transmission.

Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury.

Daniela Berg, Peter Benz, Oliver Tucha, 2002, Archives of neurology.

A highly sensitive method for the determination of protein bound 3,4-dihydroxyphenylalanine as a marker for post-translational protein hydroxylation in human tissues ex vivo

P. Riederer, M. Gerlach, M. Götz, 2001, Free radical research.

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms

P. Falkai, J. Kornhuber, A. Hasan, 2017, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Does Methylphenidate Cause a Cytogenetic Effect in Children with Attention Deficit Hyperactivity Disorder?

Susanne Walitza, Helga Stopper, Andreas Warnke, 2007, Environmental health perspectives.

Therapeutic Monitoring of Psychotropic Drugs: An Outline of the AGNP-TDM Expert Group Consensus Guideline

P. Riederer, M. Gerlach, G. Laux, 2004, Therapeutic drug monitoring.

The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration

P. Riederer, K. Double, G. Halliday, 2003, Experimental Neurology.

5-HT2A promoter polymorphism −1438G/A in children and adolescents with obsessive-compulsive disorders

B. Herpertz-Dahlmann, J. Hebebrand, A. Hinney, 2002, Molecular Psychiatry.

Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?

P. Riederer, P. Riederer, M. Gerlach, 1994, Journal of neurochemistry.

Microarray analysis reveals distinct gene expression patterns in the mouse cortex following chronic neuroleptic and stimulant treatment: implications for body weight changes

M. Gerlach, E. Grünblatt, A. Warnke, 2006, Journal of Neural Transmission.

Therapeutic Drug Monitoring in Children and Adolescents Under Pharmacotherapy With Olanzapine in Daily Clinical Practice

M. Gerlach, C. Wewetzer, K. Egberts, 2017, Therapeutic drug monitoring.

Non-Fatal Intoxication with a High Dose of Citalopram in a Suicidal 14-Year-Old Girl.

M. Gerlach, T. Vloet, K. Egberts, 2019, Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie.

Parkinson’s Disease and Related Disorders

H. Reichmann, P. Riederer, M. Gerlach, 2006 .

[Therapeutic drug monitoring in child and adolescent psychiatry--practical recommendations].

M. Gerlach, A. Warnke, C. Wewetzer, 2006, Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie.

Therapeutic drug monitoring of sertraline in children and adolescents: A naturalistic study with insights into the clinical response and treatment of obsessive-compulsive disorder.

M. Kaess, P. Heuschmann, C. Correll, 2022, Comprehensive psychiatry.

Psychostimulants and Other Drugs Used in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

L. Greenhill, S. Walitza, M. Gerlach, 2014 .

Case report: intoxication with high dose of long-acting methylphenidate (Concerta®) in a suicidal 14-year-old girl

M. Gerlach, A. Warnke, B. Pfuhlmann, 2010, Attention deficit and hyperactivity disorders.

Special Features of Psychopharmacological Therapy in Children and Adolescents

L. Greenhill, M. Gerlach, A. Warnke, 2014 .

Value of a web-based pediatric drug information system to prevent serious adverse drug reactions in child and adolescent psychiatry

M. Gerlach, J. König, K. Egberts, 2022, Journal of Neural Transmission.

["Therapeutic drug monitoring", a strategy for improving drug safety in child and adolescent psychiatry and psychotherapy].

M. Gerlach, J. Fegert, E. Schulz, 2005, Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie.

Transmission disequilibrium studies in children and adolescents with obsessive-compulsive disorders pertaining to polymorphisms of genes of the serotonergic pathway

B. Herpertz-Dahlmann, J. Hebebrand, A. Hinney, 2004, Journal of Neural Transmission.

Depression in Parkinson's disease: biogenic amines in CSF of “de novo” patients

H. Przuntek, M. Gerlach, W. Kuhn, 2005, Journal of Neural Transmission.

Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: Implications for Parkinson's disease?

H. Przuntek, P. Riederer, M. Gerlach, 1991, Neuroscience Letters.

Pharmacology of selegiline

P. Riederer, M. Gerlach, M. Youdim, 1996, Neurology.

Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample

Andreas Warnke, Marcel Romanos, M. Gerlach, 2009, Journal of Epidemiology & Community Health.

Neuroprotective therapeutic strategies. Comparison of experimental and clinical results.

P. Riederer, M. Gerlach, M. Youdim, 1995, Biochemical pharmacology.

Parkinson's disease: a major hypokinetic basal ganglia disorder

P. Riederer, P. Riederer, M. Gerlach, 1999, Journal of Neural Transmission.

Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease.

P. Riederer, R. Ravid, M. Gerlach, 2007, Journal of Alzheimer's disease : JAD.

Increased hippocampal DNA oxidation in serotonin transporter deficient mice

P. Riederer, K. Lesch, P. Riederer, 2002, Journal of Neural Transmission.

Effects of methylphenidate on olfaction and frontal and temporal brain oxygenation in children with ADHD.

Andreas Mühlberger, Andreas Warnke, Martin Schecklmann, 2011, Journal of psychiatric research.

Improved Odor Sensitivity in Attention-Deficit/Hyperactivity Disorder

H. Reichmann, P. Pauli, M. Schecklmann, 2008, Biological Psychiatry.

New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegiline.

P. Riederer, M. Gerlach, M. Youdim, 1996, Journal of neural transmission. Supplementum.

1-Trichloromethyl-1,2,3,4-tetrahydro-β-carboline increases extracellular serotonin and stimulates hydroxyl radical production in rats

P. Riederer, M. Gerlach, D. Feineis, 1998, Neuroscience Letters.

No increased chromosomal damage in l-DOPA-treated patients with Parkinson’s disease: a pilot study

S. Walitza, M. Gerlach, G. Fazeli, 2010, Journal of Neural Transmission.

A53T-Alpha-Synuclein Overexpression Impairs Dopamine Signaling and Striatal Synaptic Plasticity in Old Mice

P. Calabresi, A. Tozzi, A. Kurz, 2010, PloS one.

Relating mode of action to clinical practice: dopaminergic agents in Parkinson's disease.

H. Reichmann, P. Riederer, M. Gerlach, 2007, Parkinsonism & related disorders.

Reduced thermal hyperalgesia and enhanced peripheral nerve injury after hind paw inflammation in mice lacking the serotonin‐transporter

Claudia Sommer, Peter Riederer, K. Lesch, 2008, European journal of pain.

Responsivity of the Striatal Dopamine System to Methylphenidate—A Within-Subject I-123-β-CIT-SPECT Study in Male Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

L. Deserno, A. Buck, S. Walitza, 2022, Frontiers in Psychiatry.

Check and Double Check - the Cochrane review by Storebo et al. (2015) is indeed flawed.

T. Banaschewski, M. Gerlach, D. Coghill, 2016, Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie.

Human Stiff-Person Syndrome IgG Induces Anxious Behavior in Rats

D. Perani, M. Gerlach, M. Solimena, 2011, PloS one.

Is selegiline neuroprotective in Parkinson's disease?

P. Riederer, M. Gerlach, M. Youdim, 1994, Journal of neural transmission. Supplementum.

No cross-sectional and longitudinal association of ferritin and symptoms of attention-deficit-/hyperactivity disorder in a large population-based sample of children: results from the GINIplus and LISAplus studies

J. Heinrich, B. Hoffmann, M. Gerlach, 2013, ADHD Attention Deficit and Hyperactivity Disorders.

Amino acid specificity of glycation and protein–AGE crosslinking reactivities determined with a dipeptide SPOT library

P. Riederer, M. Gerlach, R. Schinzel, 1999, Nature Biotechnology.

No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.

S. Walitza, M. Gerlach, A. Warnke, 2009, Toxicology letters.

Brief review of available evidence concerning the potential induction of genomic damage by methylphenidate

S. Walitza, M. Gerlach, A. Warnke, 2007, Journal of Neural Transmission.

Prospective follow-up studies found no chromosomal mutagenicity of methylphenidate therapy in ADHD affected children.

S. Walitza, M. Gerlach, A. Warnke, 2010, Toxicology letters.

Pathogenesis and pathophysiology of attention-deficit/hyperactivity disorder: from childhood to adulthood

A. Rothenberger, M. Gerlach, A. Warnke, 2007, Journal of Neural Transmission.

Altered Frontal and Temporal Brain Function during Olfactory Stimulation in Adult Attention-Deficit/Hyperactivity Disorder

Andreas J. Fallgatter, Andreas Warnke, Martin Schecklmann, 2010, Neuropsychobiology.

Controlled study on the combined effect of alcohol and tobacco smoking on testosterone in alcohol-dependent men.

M. Gerlach, G. Wiesbeck, M. Walter, 2006, Alcohol and alcoholism.

Regional and age-dependent expression of the nitric oxide receptor, soluble guanylyl cyclase, in the human brain

P. Riederer, M. Gerlach, H. Schmidt, 2001, Brain Research.

Pilot study: potential transcription markers for adult attention-deficit hyperactivity disorder in whole blood

K. Lesch, P. Riederer, S. Walitza, 2012, ADHD Attention Deficit and Hyperactivity Disorders.

The Pathophysiological Basis of Parkinson’s Disease

P. Riederer, M. Gerlach, 1993 .

MPTP-Induced Parkinsonian Syndrome

P. Riederer, M. Gerlach, M. Youdim, 1999 .

Structural abnormality of the substantia nigra in children with attention-deficit hyperactivity disorder.

Joseph Classen, Andreas Warnke, Martin Schecklmann, 2010, Journal of psychiatry & neuroscience : JPN.

Dopamine receptor agonists in the therapy of Parkinson’s disease

P. Riederer, K. Double, M. Gerlach, 2004, Journal of Neural Transmission.

Brain Iron and other Trace Metals in Neurodegenerative Diseases

P. Riederer, M. Gerlach, M. Youdim, 2000 .

[Therapy with lithium salts in child and adolescent psychiatry--clinical efficacy and practical recommendations].

M. Gerlach, L. Baving, J. Fegert, 2006, Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie.

Oxytocin plasma concentrations in children and adolescents with autism spectrum disorder: correlation with autistic symptomatology

M. Schecklmann, M. Gerlach, M. Romanos, 2014, ADHD Attention Deficit and Hyperactivity Disorders.

Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals.

K. Lesch, P. Gass, M. Gerlach, 2007, Journal of neural transmission. Supplementum.

Quantitation of 5HT3 receptors in forebrain of serotonin transporter deficient mice

K. Lesch, P. Riederer, M. Gerlach, 2004, Journal of Neural Transmission.

Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study

H. Przuntek, P. Riederer, M. Gerlach, 2005, Journal of Neural Transmission.

The N-methyl-D-aspartate antagonist memantine retards progression of Huntington's disease.

M. Gerlach, W. Kuhn, M. Dose, 2004, Journal of neural transmission. Supplementum.

Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases

M. Gerlach, M. Romanos, M. Schmid, 2023, BMC Pharmacology and Toxicology.

In vivo detection of iron and neuromelanin by transcranial sonography: A new approach for early detection of substantia nigra damage

D. Berg, P. Riederer, M. Gerlach, 2005, Movement disorders : official journal of the Movement Disorder Society.

Allelic variants of SNAP25 in a family-based sample of ADHD

K. Lesch, S. Walitza, M. Gerlach, 2008, Journal of Neural Transmission.

Considerations for measuring iron in post-mortem tissue of Parkinson’s disease patients

P. Riederer, M. Gerlach, D. Hare, 2012, Journal of Neural Transmission.

Effects of the noradrenergic neurotoxin DSP4 on spatial memory in the rat

K. Lange, M. Gerlach, T. Sontag, 2007, Journal of neural transmission.

Strategies for the protection of dopaminergic neurons against neurotoxicity

P. Riederer, K. Double, M. Gerlach, 2009, Neurotoxicity Research.

Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle

P. Riederer, M. Gerlach, G. Bringmann, 2006, Journal of Neural Transmission.

Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry

J. Thome, M. Gerlach, A. Warnke, 2010, European Archives of Psychiatry and Clinical Neuroscience.

Altered peripheral BDNF mRNA expression and BDNF protein concentrations in blood of children and adolescents with autism spectrum disorder

J. Thome, M. Schecklmann, S. Walitza, 2014, Journal of Neural Transmission.

Iron-Induced Dopaminergic Cell Death In Vivo as a Model of Parkinson’s Disease

P. Riederer, K. Double, M. Gerlach, 2021, Handbook of Neurotoxicity.

Advanced glycation end products in neurodegeneration: More than early markers of oxidative stress?

P Riederer, P. Riederer, M. Gerlach, 1998, Annals of neurology.

Sustained-release of levodopa: single dose study of a new formulation

H. Przuntek, M. Gerlach, W. Kuhn, 2005, Journal of Neural Transmission.

single dose study of a new formulation

H. Przuntek, M. Gerlach, W. Kuhn, 1996 .

Determination of L-DOPA and 3-O-methyl DOPA in human plasma by extraction using C18 cartridges followed by high-performance liquid chromatographic analysis with electrochemical detection

H. Przuntek, M. Gerlach, N. Klaunzer, 1986 .

The serotonin transporter in Alzheimer's and Parkinson's disease.

K. Lesch, P. Riederer, M. Gerlach, 2000, Journal of neural transmission. Supplementum.

Altered urinary tetrahydroisoquinoline derivatives in patients with Tourette syndrome: reflection of dopaminergic hyperactivity?

V. Roessner, S. Walitza, M. Gerlach, 2020, Journal of Neural Transmission.

Therapeutic drug monitoring as a measure of proactive pharmacovigilance in child and adolescent psychiatry

M. Gerlach, K. Egberts, M. Romanos, 2016, Expert opinion on drug safety.

[Drug therapy in child and adolescent psychiatry in Germany between ethical as well as social and legal conflicts].

M. Gerlach, A. Warnke, 2016, Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie.

Neuropsychiatric disorders : an integrative approach

K. Double, M. Gerlach, J. Deckert, 2007 .

Early Detection of Parkinson’s Disease: Unmet Needs

P. Riederer, J. Winkler, M. Gerlach, 2008, Neurodegenerative Diseases.

Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis.

P Riederer, L. Grinberg, R. Leite, 2013, Journal of proteomics.

The Role of Altered Glutathione Status in the Development of Parkinson’s Disease

P. Riederer, M. Gerlach, J. Sian, 2018, Glutathione in the Nervous System.

Oxidative stress in the brain at early preclinical stages of mouse scrapie

P. Riederer, M. Gerlach, Seong-Wook Yun, 2006, Experimental Neurology.

Guidelines for the standardized collection of blood-based biomarkers in psychiatry: Steps for laboratory validity – a consensus of the Biomarkers Task Force from the WFSBP

C. Gallo, P. Lewczuk, S. Kennedy, 2019, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic

C. Wessig, S. Hallermann, M. Gerlach, 2010 .

Arguments for the use of dopamine receptor agonists in clinical and preclinical Parkinson's disease.

H. Reichmann, P. Riederer, K. Double, 2003, Journal of neural transmission. Supplementum.

The relevance of preclinical studies for the treatment of Parkinson's disease

P. Riederer, M. Gerlach, P. Foley, 2003, Journal of Neurology.

Spiked human substantia nigra proteome data set for use as a spectral library for protein modelling and protein mapping

Katrin Marcus, Caroline May, Simone Steinbach, 2019, Data in brief.

Fundamentals of Neuropsychopharmacology

M. Gerlach, 2014 .

Neural degeneration in Parkinson's disease.

K. Lesch, H. Reichmann, K. Lange, 2001, Advances in neurology.

Interaction of attention and graphomotor functions in children with attention deficit hyperactivity disorder.

K. Lange, S. Walitza, M. Gerlach, 2007, Journal of neural transmission. Supplementum.

What are the benefits of methylphenidate as a treatment for children and adolescents with attention-deficit/hyperactivity disorder?

L. Rohde, T. Banaschewski, M. Gerlach, 2017, ADHD Attention Deficit and Hyperactivity Disorders.

The industrial chemical Tinuvin 123 does not induce dopaminergic neurotoxicity in C57Bl/6 mice

P. Riederer, K. Double, M. Gerlach, 2000, Neuroscience Letters.

Characterization and regional distribution of nitric oxide synthase in the human brain during normal ageing

P. Riederer, M. Gerlach, F. Leblhuber, 1999, Brain Research.

Olfaction in child and adolescent anorexia nervosa

A. Fallgatter, M. Schecklmann, M. Gerlach, 2012, Journal of Neural Transmission.

Transmission disequilibrium studies in early onset of obsessive–compulsive disorder for polymorphisms in genes of the dopaminergic system

B. Herpertz-Dahlmann, K. Lange, A. Hinney, 2008, Journal of Neural Transmission.

Regional distribution and characterization of nitric oxide synthase activity in the brain of the common marmoset.

H. Reichmann, K. Lange, P. Riederer, 1995 .

University of Groningen Perception in attention deficit hyperactivity disorder

M. Gerlach, O. Tucha, A. Fuermaier, 2017 .

Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat

G. Halliday, M. Gerlach, J. Henderson, 2003, Behavioural Brain Research.

Evaluation of the efficacy and effectiveness of a structured disorder tailored psychotherapy in ADHD in adults: study protocol of a randomized controlled multicentre trial

M. Gerlach, A. Warnke, A. Philipsen, 2010, Attention deficit and hyperactivity disorders.

Aspirin as a free radical scavenger: consequences for therapy of cerebrovascular ischemia.

M. Gerlach, W. Kuhn, T. Müller, 1995, Stroke.

Contents of Volumes in the Metal Ions in Life Sciences Series

Jennifer C. Lee, T. Bayer, H. Gray, 2019, Metal Ions in Bio-Imaging Techniques.

Expression analyses of the mitochondrial complex I 75-kDa subunit in early onset schizophrenia and autism spectrum disorder: increased levels as a potential biomarker for early onset schizophrenia

J. Thome, M. Gerlach, R. Taurines, 2010, European Child & Adolescent Psychiatry.

Increased mRNA levels of the mitochondrial complex I 75-kDa subunit

M. Gerlach, A. Warnke, C. Mehler-Wex, 2006, European Child & Adolescent Psychiatry.

Genotoxicity of the neurotransmitter dopamine in vitro.

S. Walitza, M. Gerlach, G. Fazeli, 2009, Toxicology in vitro : an international journal published in association with BIBRA.

Responsivity of the striatal dopamine system to methylphenidate - a within-subject I-123-Î²-CIT-SPECT study in children and adolescents with Attention-Deficit/Hyperactivity Disorder

L. Deserno, S. Walitza, M. Gerlach, 2021, medRxiv.

Iron in the Parkinsonian substantia nigra.

P Riederer, K. Jellinger, E. Hirsch, 1997, Movement disorders : official journal of the Movement Disorder Society.

Olfactory deficits in deletion syndrome 22q11.2

K. Lesch, A. Fallgatter, M. Schecklmann, 2011, Schizophrenia Research.

Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs

P. Riederer, M. Gerlach, J. Heeney, 2001, Acta Neuropathologica.

Family-based association study on functional α-synuclein polymorphisms in attention-deficit/hyperactivity disorder

K. Lesch, R. Krüger, H. Conzelmann, 2019, ADHD Attention Deficit and Hyperactivity Disorders.

Genomic aspects of sporadic Parkinson's disease.

S. Mandel, P. Riederer, M. Gerlach, 2008, Parkinsonism & related disorders.

Psychiatric Drugs in Children and Adolescents

L. Greenhill, M. Gerlach, A. Warnke, 2014 .

Peer-reviewed reports on all topics relevant to attention-deficit/hyperactivity disorder

M. Gerlach, Manfred Gerlach, 2009, Attention deficit and hyperactivity disorders.

Involvement of microglia in cerebrospinal fluid glutamate increase in SIV-infected rhesus monkeys (Macaca mulatta).

P. Riederer, M. Gerlach, V. ter meulen, 1999, AIDS research and human retroviruses.

Novel mutations of the extraneuronal monoamine transporter gene in children and adolescents with obsessive-compulsive disorder.

B. Herpertz-Dahlmann, S. Walitza, M. Gerlach, 2008, The international journal of neuropsychopharmacology.

Ferritin is located within neuromelanin granules, an iron storing organelle in dopaminergic neurons of the human brain

P. Riederer, M. Gerlach, H. Meyer, 2007 .

Is there neuroprotection in Parkinson syndrome?

P. Riederer, M. Gerlach, J. Sian, 2000, Journal of Neurology.

Annual report 2015

J. Mienert, M. Gerlach, 2015, ADHD Attention Deficit and Hyperactivity Disorders.

Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample

M. Gerlach, A. Warnke, M. Romanos, 2009, Journal of Epidemiology & Community Health.

The interactions of 1-alkyl-4,4-diphenylpiperidines with opiate receptors.

H. Przuntek, M. Gerlach, P. Jutzi, 1983, European journal of pharmacology.

Relation between dosage, serum concentration and therapeutic response of risperidone in children and adolescents with schizophrenic psychosis: data from a routine TDM-Service

M. Gerlach, C. Wewetzer, K. Egberts, 2014 .

Interdisciplinary approaches for the understanding of neuropsychiatric disorders

J. Thome, P. Riederer, K. Double, 2002, Journal of Neural Transmission.

Tetrahydroisoquinoline derivatives: a new perspective on monoaminergic dysfunction in children with ADHD?

V. Roessner, A. Rothenberger, S. Walitza, 2007, Behavioral and Brain Functions.

Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's disease.

P. Riederer, K. Double, M. Gerlach, 2008, Parkinsonism & related disorders.

CLINICAL STUDY: Cortisol concentrations, stress‐coping styles after withdrawal and long‐term abstinence in alcohol dependence

M. Gerlach, G. Wiesbeck, M. Walter, 2006, Addiction biology.

Neurotransmitters and Disorders of the Basal Ganglia

P. Riederer, M. Gerlach, M. Youdim, 1999 .

Consequences of a single short lasting cerebral oligemia and the influence of iron injected into the substantia nigra or in the ventrolateral striatum of the rat. Trigger of Parkinson’s disease pathogenesis?

P. Riederer, M. Gerlach, T. Sontag, 2004, Journal of Neural Transmission.

Cerebral oligaemia episode triggers free radical formation and late cognitive deficiencies

P. Riederer, M. Gerlach, K. Sontag, 2000, The European journal of neuroscience.

Drug monitoring in child and adolescent psychiatry for improved efficacy and safety of psychopharmacotherapy

M. Gerlach, M. Kölch, J. Fegert, 2009 .

Association of Parkinson's disease with symptoms of attention deficit hyperactivity disorder in childhood.

K. Lange, S. Walitza, M. Gerlach, 2007, Journal of neural transmission. Supplementum.

Neuromelanin may Mediate Neurotoxicity via its Interaction with Redox Active Iron

P. Riederer, K. Double, M. Gerlach, 2000 .

New developments in diagnosis and treatment of Parkinson’s disease—From basic science to clinical applications

J. Schulz, R. Krüger, J. Winkler, 2004, Journal of Neurology.

AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011

Matthias J. Müller, P. Riederer, M. Gerlach, 2011, Pharmacopsychiatry.

Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity

P. Riederer, M. Gerlach, E. Grünblatt, 2014, Journal of Neural Transmission.

Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition.

C. Wessig, S. Hallermann, M. Gerlach, 2010, Brain : a journal of neurology.

The central catechol-O-methyltransferase inhibitor tolcapone increases striatal hydroxyl radical production in l-DOPA/carbidopa treated rats

P. Riederer, M. Gerlach, K. Sontag, 2009, Journal of Neural Transmission.

Time sequences of dopaminergic cell death in Parkinson's disease: indications for neuroprotective studies.

P. Riederer, M. Gerlach, 1999, Advances in neurology.

Pipamperone Population Pharmacokinetics Related to Effectiveness and Side Effects in Children and Adolescents

M. Gerlach, M. Hillegers, K. Egberts, 2020, Clinical Pharmacokinetics.

Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial

M. Kaess, C. Correll, T. Banaschewski, 2023, Pharmaceutics.

The Relation Between Dosage, Serum Concentrations, and Clinical Outcome in Children and Adolescents Treated With Sertraline: A Naturalistic Study

M. Gerlach, C. Wewetzer, K. Egberts, 2013, Therapeutic drug monitoring.

Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample

M. Gerlach, A. Warnke, M. Romanos, 2009, Journal of Epidemiology & Community Health.

Entacapone increases and prolongs the central effects of l-DOPA in the 6-hydroxydopamine-lesioned rat

C. Blaha, P. Riederer, M. Gerlach, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Laboratory assessments in the course of Parkinson’s disease: a clinician’s perspective

H. Reichmann, P. Riederer, M. Gerlach, 2015, Journal of Neural Transmission.

Evaluation of the efficacy and effectiveness of a structured disorder tailored psychotherapy in ADHD in adults: study protocol of a randomized controlled multicentre trial

M. Gerlach, A. Warnke, A. Philipsen, 2010, Attention deficit and hyperactivity disorders.